"At the time of completion of dosing with either BIT225 or placebo with IFN/RBV, i.e. week 12 of the trial, both arms had very good response rates, with 96% of subjects in the BIT225 arm having more than 2 log reduction in virus levels, compared to 90% of the placebo arm."
"Patients with undetectable virus at this time are considered cured of HCV infection."
That is sensational news!!
Happy to hold on!
